Showing results (211-220 of 239) with videos related to

Sort By:
Pageof 24
The Oncologist|June 13, 2023
Quality of Life in Male Breast Cancer: Prospective Study of the International Male Breast Cancer Program (EORTC10085/TBCRC029/BIG2-07/NABCG)Carolien P Schröder, Elise van Leeuwen-Stok, Fatima Cardoso, et al.
NPJ Breast Cancer|January 24, 2025
Unraveling complexity and leveraging opportunities in uncommon breast cancer subtypesFresia Pareja, Rohit Bhargava, Virginia F Borges, et al.
The New England Journal of Medicine|February 9, 2022
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast CancerPeter Schmid, Javier Cortes, Rebecca Dent, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2020
Standard Anthracycline Based Versus Docetaxel-Capecitabine in Early High Clinical and/or Genomic Risk Breast Cancer in the EORTC 10041/BIG 3-04 MINDACT Phase III TrialSuzette Delaloge, Martine Piccart, Emiel Rutgers, et al.
The Lancet. Oncology|January 2, 2021
Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolboxPeter Dubsky, Katja Pinker, Fatima Cardoso, et al.
The Lancet. Oncology|March 15, 2021
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by ageMartine Piccart, Laura J van 't Veer, Coralie Poncet, et al.
JAMA Oncology|January 22, 2021
Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer: A Phase 3 Randomized Clinical TrialHope S Rugo, Seock-Ah Im, Fatima Cardoso, et al.
The New England Journal of Medicine|August 25, 2016
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast CancerFatima Cardoso, Laura J van't Veer, Jan Bogaerts, et al.
Breast (Edinburgh, Scotland)|August 14, 2021
Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancyAnn H Partridge, Samuel M Niman, Monica Ruggeri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2022
Treatment Exposure and Discontinuation in the PALbociclib CoLlaborative Adjuvant Study of Palbociclib With Adjuvant Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer (PALLAS/AFT-05/ABCSG-42/BIG-14-03)Erica L Mayer, Christian Fesl, Dominik Hlauschek, et al.
Pageof 24